Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Urologic oncology

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.urolonc.2017.01.012PMID 28214283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61.

  2017cited by this paper
• Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

  2017cited by this paper
• EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

  2017cited by this paper
• Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from

  2016cited by this paper
• EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

  2016cited by this paper
• Platinum Priority – Collaborative Review – Urothelial CancerEditorial by Joan Palou, Oscar Rodriguez and Josep M. Gaya on pp. 889–890 of this issueDiagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review☆

  2015cited by this paper
• Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena

  2015cited by this paper
• Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

  2013cited by this paper
• Epidemiology and risk factors of urothelial bladder cancer.

  2013cited by this paper
• Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection.

  2012cited by this paper
• Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma.

  2012cited by this paper
• Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.

  2012cited by this paper
• Cadherin switching and bladder cancer.

  2010cited by this paper
• Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.

  2010cited by this paper
• Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

  2009cited by this paper
• Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

  2009cited by this paper
• Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness

  2007cited by this paper
• N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial Tumors

  2006cited by this paper
• Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

  2006cited by this paper
• Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

  2004cited by this paper
• Neoexpression of N‐cadherin in E‐cadherin positive colon cancers

  2004cited by this paper
• Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway

  2004cited by this paper
• Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder.

  2003cited by this paper
• Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials.

  2002cited by this paper
• E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.

  2001cited by this paper
• E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.

  2001cited by this paper
• Expression of classic cadherins type I in urothelial neoplastic progression.

  2001cited by this paper
• Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis

  2000cited by this paper
• N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells.

  1999cited by this paper
• N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression

  1999cited by this paper

• Plasticity in cell adhesion during tumor progression.

  2025cites this paper
• Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma

  2025cites this paper
• Matched serum- and urine-derived biomarkers of interstitial cystitis/bladder pain syndrome

  2024cites this paper
• Metabolomic Biomarkers for Prognosis in Non-Muscle Invasive Bladder Cancer: A Comprehensive Systematic Review and Meta-Analysis

  2024cites this paper
• New Advances in the Prediction of NMIBC Recurrence by Genetic Biomarkers

  2023cites this paper
• Non-muscle invasive bladder cancer biomarkers beyond morphology

  2022cites this paper
• Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers.

  2022cites this paper
• Oncological impact of cystoscopic findings in non‐muscle‐invasive bladder cancer: a meta‐analysis

  2022cites this paper
• The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis

  2022cites this paper
• High N-Cadherin Protein Expression in Ovarian Cancer Predicts Poor Survival and Triggers Cell Invasion

  2022cites this paper
• Attachment of Cancer Urothelial Cells to the Bladder Epithelium Occurs on Uroplakin-Negative Cells and Is Mediated by Desmosomal and Not by Classical Cadherins

  2021cites this paper
• TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9

  2021cites this paper
• Dual role of E-cadherin in cancer cells

  2021cites this paper
• Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT

  2020cites this paper
• Isoflurane promotes epithelial-to-mesenchymal transition and metastasis of bladder cancer cells through HIF-1α-β-catenin/Notch1 pathways.

  2020cites this paper
• Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples

  2020influential citation
• Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer

  2020cites this paper
• Aberrant N-cadherin expression in cancer.

  2019cites this paper
• Predictive Molecular and Protein Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer

  2019cites this paper
• Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer

  2019cites this paper
• Ubenimex, an APN inhibitor, could serve as an anti-tumor drug in RT112 and 5637 cells by operating in an Akt-associated manner

  2018cites this paper
• Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer

  2018cites this paper
• Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer

  2018cites this paper
• Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?

  2018cites this paper
• Prognostic Role of N‐cadherin Expression in Patients With Invasive Bladder Cancer

  2017influential citation